Atrium Therapeutics rises on $15 million milestone payment from Bristol Myers Squibb

Bristol-Myers Squibb Co

23/04/2026 15:13

** Shares of Atrium Therapeutics RNA.O rise 5.78% to $14.45

** Co earns $15 million development milestone payment from Bristol Myers Squibb BMY.N under global cardiovascular collaboration

** Says RNA eligible for up to about $1.35 billion in research and development milestone payments, up to about $825 million in commercial milestone payments and tiered royalties up to low double-digits on net sales

** Adds Bristol Myers Squibb to fund all future clinical development, regulatory and commercialization activities resulting from collaboration

(Reporting by Megha Anilkumar Nair)

((MeghaAnilkumar.Nair@thomsonreuters.com;))